ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway

详细信息    查看全文

• 作者：Weiwei Shan (1) (2)
  Chao Wang (3)
  Zhenbo Zhang (4)
  Xuezhen Luo (1) (2)
  Chengcheng Ning (1) (2)
  Yinhua Yu (1) (2)
  Youji Feng (4)
  Chao Gu (1) (2) (5)
  Xiaojun Chen (1) (2) (5)
  
  1. Department of Gynecology ; Obstetrics and Gynecology Hospital of Fudan University ; Shanghai ; 200011 ; People鈥檚 Republic of China
  2. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases ; Shanghai ; 200011 ; China
  3. Department of Pathology ; Obstetrics and Gynecology Hospital of Fudan University ; Shanghai ; 200011 ; People鈥檚 Republic of China
  4. Department of Gynecology ; Shanghai First People鈥檚 Hospital Affiliated to Shanghai Jiao tong University ; Shanghai ; 200081 ; China
  5. Fangxie Road 419# ; Huangpu District ; Shanghai ; People鈥檚 Republic of China
  
• 关键词：ATM ; Endometrial cancer ; Progesterone
• 刊名：Tumor Biology
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：36
• 期：3
• 页码：1529-1537
• 全文大小：1,699 KB
• 参考文献：1. Weiderpass, E, Labreche, F (2012) Malignant tumors of the female reproductive system. Saf Health Work 3: pp. 166-80 CrossRef
  2. Pfeiffer, RM, Park, Y, Kreimer, AR, Lacey, JJ, Pee, D, Greenlee, RT (2013) Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med 10: pp. e1001492 CrossRef
  3. Gallo, M, Bell, DW (2014) The emerging genomic landscape of endometrial cancer. Clin Chem 60: pp. 98-110 CrossRef
  4. Li, X, Shao, R (2014) PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma. Am J Cancer Res 4: pp. 73-9
  5. Kim, JJ, Kurita, T, Bulun, SE (2013) Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 34: pp. 130-62 CrossRef
  6. Smith, J, Tho, LM, Xu, N, Gillespie, DA (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108: pp. 73-112 CrossRef
  7. Stracker, TH, Roig, I, Knobel, PA, Marjanovic, M (2013) The ATM signaling network in development and disease. Front Genet 4: pp. 37 CrossRef
  8. Fan, C, Quan, R, Feng, X, Gillis, A, He, L, Matsumoto, ED (2006) ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochim Biophys Acta 1763: pp. 1090-7 CrossRef
  9. Puccini, J, Shalini, S, Voss, AK, Gatei, M, Wilson, CH, Hiwase, DK (2013) Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice. Proc Natl Acad Sci U S A 110: pp. 19920-5 CrossRef
  10. Selvarajah, J, Nathawat, K, Moumen, A, Ashcroft, M, Carroll, VA (2013) Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways. Cell Death Dis 4: pp. e865 CrossRef
  11. Takagi, M, Sato, M, Piao, J, Miyamoto, S, Isoda, T, Kitagawa, M (2013) ATM-dependent DNA damage-response pathway as a determinant in chronic myelogenous leukemia. DNA Repair (Amst) 12: pp. 500-7 CrossRef
  12. Vang, R, Gown, AM, Barry, TS, Wheeler, DT, Ronnett, BM (2006) Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Mod Pathol 19: pp. 97-105 CrossRef
  13. Zhao, S, Li, G, Yang, L, Li, L, Li, H (2013) Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate. Oncol Lett 5: pp. 139-44
  14. Zhang, L, Wei, Q, Mao, L, Liu, W, Mills, GB, Coombes, K (2009) Serial dilution curve: a new method for analysis of reverse phase protein array data. Bioinformatics 25: pp. 650-4 CrossRef
  15. Tsuda, H, Hashiguchi, Y, Inoue, T, Yamamoto, K (2003) Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium. Oncol-Basel 65: pp. 159-66 CrossRef
  16. Einarsdottir, K, Humphreys, K, Bonnard, C, Li, Y, Li, Y, Chia, KS (2007) Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. Hum Mol Genet 16: pp. 154-64 CrossRef
  17. Mirzayans, R, Andrais, B, Scott, A, Murray, D (2012) New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed Biotechnol 2012: pp. 170325 CrossRef
  18. Choi, JD, Lee, JS (2013) Interplay between epigenetics and genetics in cancer. Genomics Inform 11: pp. 164-73 CrossRef
  19. Masai, H (2014) ATM in prevention of genomic instability. Cell Cycle 13: pp. 882-3 CrossRef
  20. Kim, M, Park, HJ, Seol, JW, Jang, JY, Cho, YS, Kim, KR (2013) VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy. EMBO Mol Med 5: pp. 1415-30 CrossRef
  21. Wang, J, Taylor, A, Showeil, R, Trivedi, P, Horimoto, Y, Bagwan, I (2014) Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma. Cytokine 68: pp. 94-100 CrossRef
  22. Gu, C, Zhang, Z, Yu, Y, Liu, Y, Zhao, F, Yin, L (2011) Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer. Cancer Sci 102: pp. 557-64 CrossRef
  23. Kauff, ND (2009) ATR mutations in endometrial cancer: a window into the role of mismatch repair defects. J Clin Oncol 27: pp. 3077-8 CrossRef
  24. Banno, K, Kisu, I, Yanokura, M, Tsuji, K, Masuda, K, Ueki, A (2012) Biomarkers in endometrial cancer: possible clinical applications (review). Oncol Lett 3: pp. 1175-80
  25. Tommiska, J, Bartkova, J, Heinonen, M, Hautala, L, Kilpivaara, O, Eerola, H (2008) The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene 27: pp. 2501-6 CrossRef
  26. Liang, Y, Lin, SY, Brunicardi, FC, Goss, J, Li, K (2009) DNA damage response pathways in tumor suppression and cancer treatment. World J Surg 33: pp. 661-6 CrossRef
  27. Yang, DQ, Halaby, MJ, Li, Y, Hibma, JC, Burn, P (2011) Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration. Drug Discov Today 16: pp. 332-8 CrossRef
  28. Kim, JW, Im, SA, Kim, MA, Cho, HJ, Lee, DW, Lee, KH (2014) Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker. Int J Cancer 134: pp. 72-80 CrossRef
  29. Guo, X, Yang, C, Qian, X, Lei, T, Li, Y, Shen, H (2013) Estrogen receptor alpha regulates ATM expression through miRNAs in breast cancer. Clin Cancer Res 19: pp. 4994-5002 CrossRef
  30. Wilk, A, Waligorska, A, Waligorski, P, Ochoa, A, Reiss, K (2012) Inhibition of ERbeta induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines. PLoS One 7: pp. e33867 CrossRef
  31. Bozhanov, SS, Angelova, SG, Krasteva, ME, Markov, TL, Christova, SL, Gavrilov, IG (2010) Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer. J Cancer Res Clin Oncol 136: pp. 1657-69 CrossRef
  32. Mhawech-Fauceglia, P, Wang, D, Kim, G, Sharifian, M, Chen, X, Liu, Q (2014) Expression of DNA repair proteins in endometrial cancer predicts disease outcome. Gynecol Oncol 132: pp. 593-8 CrossRef
  33. Fang, S, Krahe, R, Lozano, G, Han, Y, Chen, W, Post, SM (2010) Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS One 5: pp. e10813 CrossRef
  34. Hirshfield, KM, Rebbeck, TR, Levine, AJ (2010) Germline mutations and polymorphisms in the origins of cancers in women. J Oncol 2010: pp. 297671 CrossRef
  35. Lei, W, Feng, XH, Deng, WB, Ni, H, Zhang, ZR, Jia, B (2012) Progesterone and DNA damage encourage uterine cell proliferation and decidualization through up-regulating ribonucleotide reductase 2 expression during early pregnancy in mice. J Biol Chem 287: pp. 15174-92 CrossRef
  36. Sun, Y, Jiang, X, Price, BD (2010) Tip60: connecting chromatin to DNA damage signaling. Cell Cycle 9: pp. 930-6 CrossRef
  37. Xu, Y, Tong, J, Ai, Z, Wang, J, Teng, Y (2012) Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: in a mouse model. J Obstet Gynaecol Res 38: pp. 1358-66 CrossRef
  38. Arnold, JT, Lessey, BA, Seppala, M, Kaufman, DG (2002) Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res 62: pp. 79-88
  
• 刊物主题：Cancer Research;
• 出版者：Springer Netherlands
• ISSN：1423-0380

文摘

The purpose of the study was to explore the role and mechanism of ataxia-telangiectasia mutated (ATM) protein in endometrial carcinogenesis. A reverse-phase protein array (RPPA) was used to analyze the expression of ATM signal pathway proteins in Ishikawa and progesterone-insensitive Ishikawa. ATM expression was detected in endometrium specimens by immunohistochemistry, including 8 cases with proliferative endometrium, 6 cases with secretory endometrium, 10 cases with simple hyperplasia (SH), 13 cases of complex hyperplasia (CH), 11 cases of endometrial atypical hyperplasia (EAH), and 83 cases with type I endometrial cancer. The relationship between ATM expression and other clinicopathological indicators was also examined in type I endometrial cancer patients. The mechanisms of ATM were explored in vitro with the endometrial cell lines Ishikawa and RL95-2. A cell counting kit-8 (CCK-8) test and Western blot analysis were performed to test proliferation and protein expression. Statistical analysis was performed with SPSS19.0. The significance level was set at 0.05. ATM was increased with medroxyprogesterone acetate (MPA) stimulation in Ishikawa in RPPA. ATM expression gradually decreased in endometrial hyperplasic lesions compared with the normal proliferative and secretory endometrium and was the lowest in type I endometrial cancer. ATM expression was negatively correlated with pathological grades in type I endometrial cancer. In vitro, ATM silencing retarded proliferation inhibition in Ishikawa and RL95-2 treated with MPA. ATM silencing could down-regulate the MPA-stimulated signal proteins, including Chk2, P53, and caspase-3 in vitro. MPA might exert its role through activating the ATM-associated pathway, ATM-Chk2-P53-caspase-3 (active), preserving normal endometrium and protecting it from malignancies. ATM might be a promising indicator for endometrial hyperplasia and cancer.